Composition and method for treating iron deficiency syndrome
Patent 4415555 Issued on November 15, 1983. Estimated Expiration Date: 
March 17, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 17, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3650704 3829561 InventorsAssigneeApplicationNo. 06/359126 filed on 03/17/1982US Classes:424/648, Ferrous423/420.2, Plural metal containing423/554, Alkaline earth metal containing (Mg, Ca, Sr, or Ba)514/502, Iron514/814, ANEMIA556/27Aluminum containingExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassesA61K 35/02 (20060101)A61K 33/26 (20060101) A61K 31/295 (20060101) A61K 31/28 (20060101) Foreign Application Priority Data1981-03-24 JPAbstractA composition for treating an iron deficiency disease, composed of (1) an amount, effective for treating said disease, of a compound having a hydrotalcite-like crystal structure and represented by the following formulawherein An- represents an anion having a valence of n, Mg2+ is within the range of OࣘMg2+ <x, Fe3+ is within the range of OࣘFe3+ 2, x is a number represented by 1ࣘ×<20, z is a number represented by 0<z<3, and m is a number represented by Oࣘm<8, and (2) a pharmaceutically acceptable diluent or carrier, and a method for treating an iron deficiency disease, which comprises orally administering an amount, effective for treating said disease, of the compound represented by the aforesaid formula. |
| ||||||||||||||
